ClinicalTrials.gg
RecruitingNCT07926815Updated Nov 9, 2026

An Intervention to Improve the Experience of Patients in Intermediate and Long-term Care Units

An observational study in Patient Satisfaction and Patient Experience, sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. Recruiting at 1 site in Spain. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Consorci Sanitari de l'Alt Penedès i Garraf · Observational

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.
Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
186
Sex
All
01

Study summary

The goal of this clinical trial is to learn if an intervention that detects and addresses the problems perceived by patients during their hospital stay can improve trust in the hospital among older patients admitted to intermediate and long-term care units. The main questions it aims to answer are:

  • Does the intervention increase patients' trust in the hospital, measured as their likelihood of recommending it?
  • Does the intervention reduce formal complaints, improve patients' emotional well-being, and improve the job satisfaction of nursing staff? Researchers will compare patients admitted before the intervention was introduced with patients admitted one year after it was introduced to see if trust in the hospital improves.

Participants will:

  • Complete, after one month of admission, the hospital's satisfaction questionnaire (which includes the trust question) and a short emotional well-being questionnaire, either themselves or through a relative or caregiver
  • In the post-intervention period, be interviewed between days 10 and 15 of admission about the negative aspects of their stay; the results are discussed at multidisciplinary team meetings, where corrective actions are agreed Nursing staff and nursing assistants on the participating wards will complete a job satisfaction questionnaire before and after the intervention.
Read the detailed description

This is a quasi-experimental before-and-after study. The primary outcome will be collected cross-sectionally from all eligible patients admitted at a given time before the intervention is implemented, and again from eligible patients admitted one year after implementation. Formal complaints will be collected retrospectively for the year before the intervention and for the intervention year. Patient questionnaires will be completed on paper without personal information and returned in a sealed envelope identified only by a participant code; the envelopes will be opened by independent research staff, and analysts will be blinded to the study period.

The primary analysis will compare the primary outcome between the pre- and post-intervention groups using a superiority approach, with parametric or non-parametric tests as appropriate and multivariable adjustment for potential confounders that differ between periods. Subgroup analyses by type of ward (conventional vs psychogeriatric) are planned. With 93 patients per group, the study has more than 80% power (two-sided alpha 0.05) to detect an increase in the proportion of patients with trust in the institution (score above 7) from 30% to 50%.

02

Conditions studied

  • Patient Satisfaction
  • Patient Experience

Browse trials for

Keywords

  • long-term care
  • intermediate care
  • quality of health care
03

In context

Patient Satisfaction

877 studies on the registry are indexed under Patient Satisfaction; 202 are open to participants now.

This study's planned enrollment of 186 is above the median of 149 across 225 observational studies indexed under Patient Satisfaction.

Browse Patient Satisfaction studies →

Lead sponsor

Consorci Sanitari de l'Alt Penedès i Garraf is the lead sponsor of 41 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients admitted to intermediate and long-term care units

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Admitted to an intermediate or long-term care unit of Hospital Sant Antoni Abat
  • Length of stay of at least 1 month
  • Patient and/or caregiver able to take part in the study assessments
  • Signed , given by the patient or by the patient's legal representative

Exclusion criteria

Exclusion Criteria:

  • Cognitive or affective disorder that limits the ability to answer the study questionnaires, with no reference person available to answer on the patient's behalf
  • Participation in another study involving an experimental intervention during the period of this study and/or with a visit schedule incompatible with this study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
186 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pre-intervention

    Patients admitted to intermediate and long-term care units before the intervention is implemented, receiving usual care

  • Post-intervention

    Patients admitted to the same units one year after the intervention is implemented

    Other: Patient experience intervention (problem-detection interview and multidisciplinary action plan)

Interventions

  • OtherPatient experience intervention (problem-detection interview and multidisciplinary action plan)

    Between days 10 and 15 of admission, patients (or their relatives or caregivers) are interviewed following a structured script about the negative aspects they perceive in their hospital stay, including quality of care, comfort, medical information, and assistance with daily activities. Responses are classified using the Net Promoter Score framework. The results are presented at the periodic multidisciplinary team meetings, where a personalized action plan is agreed, documented in the clinical record with assigned responsibilities and deadlines, and reassessed at approximately 30 days.

06

What researchers measure

Primary outcomes

  1. Trust in the institution

    Score on the question "If needed, would you recommend Hospital Sant Antoni Abat?" from the hospital's inpatient satisfaction questionnaire, rated from 0 (would never recommend) to 10 (would actively recommend). Higher scores indicate greater trust. A score above 7 is considered to indicate trust in the institution.

    Time frame: After 1 month of admission, in the pre-intervention group and in the post-intervention group

07

Study locations

1 of 1 sites recruiting
  • Hospital Sant Antoni Abat-Consorci Sanitari Alt Penedès-Garraf
    Vilanova i la Geltrú, Barcelona, Spain
    Recruiting
    • Noemí Casaponsa · Contactrecerca@csapg.cat · 0034938960025
    • Helena Camell · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

Supporting information: Study protocol

Time frame: After publication of main results of the study

Access criteria: IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Dec 2027, 25 months after the start.

Of 105 non-industry observational studies under Patient Satisfaction, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 45. This study's planned 25 months is above that.

Counting every sponsor, half of 111 studies reached it within 20 months; a quarter within 7 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 9, 2026
StartActual
Nov 21, 2025
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926815
Lead sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Responsible party
Sponsor
First posted
Nov 9, 2026
Start date
Nov 21, 2025
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Noemí Casaponsa
Contact
recerca@csapg.cat
0034938960025 ext. 43197

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion